Company: TVRD
Filing Date: 2025-05-13
Form Type: 8-K/A
Source: 0001104659-25-047844
Chunk: 2

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-13
Form: 8-K/A
Chunk 2
---
 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired

The unaudited financial statements
of Private Tvardi for the quarter ended March 31, 2025 are filed as Exhibit 99.6 to this Amendment No. 1 and are incorporated herein by
reference.

(d) Exhibits

| Exhibit No. 
 99.6        
 99.7        |     | Description                                                                                                                                    
 Condensed Financial Statements of Tvardi Therapeutics, Inc. for the quarter ended March 31, 2025 (Unaudited).                                  
 Management’s Discussion and Analysis of Financial Condition and Results of Operations for Private Tvardi for the quarter ended March 31, 2025. |
|:------------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------|
| 104         |     | Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                   |

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

| Date: May 13, 2025 | TVARDI THERAPEUTICS, INC. 
 By:                       | /s/                     
 Imran Alibhai           |
|:-------------------|:--------------------------|:------------------------|
|                    | Name:                     | Imran Alibhai           |
|                    | Title:                    | Chief Executive Officer |

<div align='center'>2</div>